Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Asset Writedowns and Impairment (2020 - 2026)

RxSight filings provide 6 years of Asset Writedowns and Impairment readings, the most recent being $616000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 767.61% to $616000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 378.22% increase, with the full-year FY2025 number at $1.9 million, up 378.22% from a year prior.
  • Asset Writedowns and Impairment hit $616000.0 in Q4 2025 for RxSight, up from $66000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.8 million in Q2 2021 to a low of -$7000.0 in Q1 2021.
  • Median Asset Writedowns and Impairment over the past 5 years was $72000.0 (2022), compared with a mean of $280950.0.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 100.3% in 2023 and later skyrocketed 16700.0% in 2024.
  • RxSight's Asset Writedowns and Impairment stood at $10000.0 in 2021, then surged by 2880.0% to $298000.0 in 2022, then tumbled by 49.33% to $151000.0 in 2023, then plummeted by 52.98% to $71000.0 in 2024, then soared by 767.61% to $616000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $616000.0 (Q4 2025), $66000.0 (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.